Salubris Biotherapeutics

SalubrisBio, founded in August 2016, is a wholly-owned subsidiary of the Chinese pharmaceutical company Salubris Pharmaceuticals Co., Ltd. SalubrisBio is an innovative biotechnology company dedicated to the discovery and development of novel antibody and protein therapies. Its key focus areas are cardiovascular diseases, oncology, and neurodegenerative diseases, which are the three leading causes of death worldwide today. Headquartered in the United States, SalubrisBio reflects Salubris Pharmaceuticals' commitment to innovation and global market expansion while upholding its core mission of developing therapies for large underserved patient populations.